Definitive Healthcare (NASDAQ:DH) PT Lowered to $7.00 at Deutsche Bank Aktiengesellschaft

Definitive Healthcare (NASDAQ:DH - Free Report) had its price objective trimmed by Deutsche Bank Aktiengesellschaft from $10.00 to $7.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has a hold rating on the stock.

A number of other equities research analysts have also commented on DH. Barclays dropped their price objective on shares of Definitive Healthcare from $11.00 to $7.00 and set an equal weight rating on the stock in a report on Thursday. Canaccord Genuity Group cut their price target on Definitive Healthcare from $10.00 to $8.00 and set a hold rating on the stock in a report on Wednesday. Needham & Company LLC reissued a hold rating on shares of Definitive Healthcare in a research report on Wednesday. Morgan Stanley downgraded Definitive Healthcare from an overweight rating to an equal weight rating and reduced their price target for the stock from $11.50 to $9.00 in a research report on Wednesday. Finally, Stifel Nicolaus lowered their price objective on shares of Definitive Healthcare from $11.00 to $9.50 and set a buy rating on the stock in a report on Wednesday. Nine analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of Hold and an average price target of $9.94.

Definitive Healthcare Trading Down 3.4 %

Shares of DH traded down $0.18 on Thursday, reaching $5.17. 3,323,524 shares of the company's stock were exchanged, compared to its average volume of 643,916. The business has a 50 day moving average price of $7.70 and a two-hundred day moving average price of $8.29. Definitive Healthcare has a 12 month low of $4.38 and a 12 month high of $12.45. The stock has a market capitalization of $608.97 million, a P/E ratio of -2.86, a price-to-earnings-growth ratio of 6.12 and a beta of 1.41. The company has a current ratio of 2.31, a quick ratio of 2.31 and a debt-to-equity ratio of 0.20.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last released its earnings results on Wednesday, February 28th. The company reported ($0.01) earnings per share for the quarter, missing the consensus estimate of $0.01 by ($0.02). The company had revenue of $65.93 million during the quarter, compared to analyst estimates of $66.01 million. Definitive Healthcare had a negative net margin of 80.40% and a positive return on equity of 0.43%. Research analysts anticipate that Definitive Healthcare will post 0.11 earnings per share for the current year.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Massachusetts Financial Services Co. MA increased its stake in shares of Definitive Healthcare by 76.0% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 3,466,514 shares of the company's stock valued at $34,457,000 after buying an additional 1,496,652 shares during the period. Conestoga Capital Advisors LLC increased its position in Definitive Healthcare by 12.1% during the 4th quarter. Conestoga Capital Advisors LLC now owns 5,521,137 shares of the company's stock valued at $54,880,000 after purchasing an additional 595,280 shares during the period. Vanguard Group Inc. raised its holdings in Definitive Healthcare by 6.2% during the 3rd quarter. Vanguard Group Inc. now owns 4,331,543 shares of the company's stock worth $34,609,000 after purchasing an additional 254,726 shares during the last quarter. Raymond James & Associates lifted its position in shares of Definitive Healthcare by 41.6% in the 1st quarter. Raymond James & Associates now owns 844,814 shares of the company's stock worth $6,818,000 after purchasing an additional 248,266 shares during the period. Finally, Bank of New York Mellon Corp lifted its position in shares of Definitive Healthcare by 11.7% in the 3rd quarter. Bank of New York Mellon Corp now owns 1,090,136 shares of the company's stock worth $8,710,000 after purchasing an additional 113,963 shares during the period. Institutional investors own 98.67% of the company's stock.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.